Tobacco Smoke Exposure Unlikely to Worsen Atopic Dermatitis in Youth
A comprehensive study finds no significant link between exposure to tobacco smoke and the severity or activity of atopic dermatitis in children and adolescents.
Related Articles
POLL: Which Anticipated Drug Approval/PDUFA Date Are You Most Looking Forward to in 2025?
Share your insights and anticipation with us.
Study Links Psoriasis to Increased Dementia Risk
A large population-based cohort study has identified a modestly increased risk of dementia in individuals with psoriasis.
Carbon Footprint Analysis of an Outpatient Dermatology Practice at an Academic Medical Center
This quality improvement study aims to quantify the annual greenhouse gas emissions from a large outpatient dermatology practice, compare relative sources of emissions, and identify…
Optimal Disitamab Vedotin Dose for Patients With Chemotherapy-Refractory Advanced Urothelial Carcinoma
According to results from the phase 1b/2 RC48-C014 study, the addition of 2 mg/kg of disitamab vedotin to toripalimab is preferable to 1.5 mg/kg among…
The Impact of Anti-Inflammatory Moisturizers in Mild to Moderate Atopic Dermatitis Treatment
More improved skin hydration and barrier function was observed in moisturizers with anti-inflammatory ingredients, compared to those without.
29th Annual Acute Leukemia Forum 2025 | La Jolla, California
Register now and explore groundbreaking advancements in acute leukemia and myelodysplasia treatment at ALF 2025. Stay informed with the latest innovations shaping the future of…
Mosunetuzumab Plus Polatuzumab Vedotin Shows Improved Outcomes vs Rituximab Plus Polatuzumab Vedotin Among Patients With R/R Large B-Cell Lymphoma
Subcutaenous mosunetuzumab plus polatuzumab vedotin demonstrates improved efficacy and response rates compared with rituximab plus polatuzumab vedotin for patients with relapsed/refractory (R/R) LBCL, according to…
VYNE Completes Phase 2b Enrollment for Vitiligo Gel
Repibresib’s localized delivery minimizes systemic exposure while targeting inflammatory pathways, a novel approach for vitiligo management.
Quoin Pharmaceuticals’ Announces Positive Interim QRX003 Data for Netherton Syndrome
The results showed promising improvements in all endpoints with high patient satisfaction and no safety concerns.
Organic Filter-Based Sunscreens are Safe, Effective, and User-Friendly for Sensitive Skin
After 8 weeks of use, the product showed improvements in skin sensitivity, transepidermal water loss, and skin corneum hydration.